There has been dramatic growth in the number of intravitreal injections performed annually. This paper features expert panel consensus regarding the use of intravitreal injections and serves as an ...

We report a case of posterior lens nucleus displacement following an intravitreal injection of bevacizumab (IVB). To the best of our knowledge this complication has not been previously reported. A ...

Povidone-iodine is the most commonly used antiseptic for the ocular surface. It is also used for the prophylaxis of infection in eyes undergoing intravitreal injection. Published endophthalmitis rates ...

To evaluate the safety of a nurse practitioner (NP)-delivered injection service for the treatment of wet age-related macular degeneration (wAMD) with ranibizumab. An evaluation of medical staffing ...

Patients completed a questionnaire that assessed the impact of intravitreal injections on quality of life This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, ...

Please provide your email address to receive an email when new articles are posted on . I believe intravitreal injections are best performed in the office for many reasons. First of all, it is safe.

Please provide your email address to receive an email when new articles are posted on . In the past decade, intravitreal injections have transformed the way that we treat retinal disease, particularly ...

A low risk of adverse safety outcomes was observed in anti–vascular endothelial growth factor (VEGF) intravitreal injections performed in office-based and operating room settings, with a higher rate ...

Adipose tissue–derived “stem cells” have been increasingly used by “stem-cell clinics” in the United States and elsewhere to treat a variety of disorders. We evaluated three patients in whom severe ...

A history of multiple past intravitreal injections (IVIs) poses a risk for certain future cataract surgery complications, according to a study presented at the annual meeting of the American Academy ...

In a first of its kind study, Mount Sinai researchers are using optimal coherence tomography angiography (OCTA) to measure potential retina damage from long-term use of intravitreal eye injections.